← FDA Drug Approvals (Drugs@FDA)
RIVAROXABAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2022-06-27
Drug application
- FDA Application #
ANDA212220- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIVAROXABAN
- Generic name
- Rivaroxaban
- Active ingredients
- RIVAROXABAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN PHARMS INC
- First approval
- 2022-06-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown